ARDS, HUMAN
Clinical trials for ARDS, HUMAN explained in plain language.
Never miss a new study
Get alerted when new ARDS, HUMAN trials appear
Sign up with your email to follow new studies for ARDS, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Clot-Fighting strategy for kidney machines during life support shows promise
Disease control CompletedThis study looked at 18 ICU patients on both a heart-lung bypass machine (ECMO) and a kidney replacement therapy machine. Researchers tested whether adding a special blood thinner (citrate) to the kidney machine could prevent clotting better than standard care. The goal was to ke…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated May 26, 2026 11:13 UTC
-
New lung support strategy tested in 676 ICU patients
Disease control CompletedThis study tested whether using a special imaging technique (EIT) to set breathing machine pressure helps people with ARDS survive longer compared to the standard low-pressure method. 676 adults on breathing machines took part. The goal was to see which approach leads to better 2…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Blood filtering shows promise for severe COVID-19 breathing problems
Disease control CompletedThis study tested a treatment called therapeutic plasma exchange (TPE) for people with severe COVID-19. TPE filters the blood to remove harmful inflammatory substances that can cause breathing failure. The study compared standard intensive care alone to standard care plus TPE in …
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 26, 2026 11:05 UTC
-
Experimental stem cell infusion tested in 7 critically ill COVID patients
Disease control CompletedThis early-stage study tested a single dose of mesenchymal stromal cells (a type of stem cell) in 7 adults with severe COVID-19-related lung failure who were on ventilators. The main goal was to check safety by watching for serious side effects like heart problems or blood clots …
Matched conditions: ARDS, HUMAN
Phase: PHASE1 • Sponsor: Uppsala University • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New ventilation approach for ARDS shows promise in small study
Knowledge-focused CompletedThis study looked at a new way to set breathing machines for people with severe lung injury (ARDS). The method uses pressure measurements inside the lungs to adjust settings. Nine adults with moderate to severe ARDS took part. The goal was to see if the method is safe and how it …
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC